Literature DB >> 23329717

Leucocytoclastic vasculitis as a late complication of clopidogrel therapy.

Ranjan K Shetty1, Mohit Madken, Kushal Naha, G Vivek.   

Abstract

We describe a case of leucocytoclastic vasculitis manifested as exanthematous rash in a 57-year-old woman on long-term therapy with clopidogrel. The diagnosis was confirmed by skin biopsy. The patient was managed symptomatically with oral antihistaminics and topical steroids in consultation with dermatologists. Clopidogrel therapy was discontinued on suspicion of drug-induced vasculitis. The rash resolved completely within 2 weeks of withdrawal of clopidogrel, satisfying criteria for a probable adverse drug reaction. Leucocytoclastic vasculitis is an unusual adverse effect of clopidogrel therapy and even rarer as a late complication.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23329717      PMCID: PMC3604531          DOI: 10.1136/bcr-2012-007861

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  Characterization of clopidogrel hypersensitivity reactions and management with oral steroids without clopidogrel discontinuation.

Authors:  Asim N Cheema; Atif Mohammad; Tony Hong; Henry R Jakubovic; Gurpreet S Parmar; Waseem Sharieff; M Bernadette Garvey; Michael J B Kutryk; Neil P Fam; John J Graham; Robert J Chisholm
Journal:  J Am Coll Cardiol       Date:  2011-09-27       Impact factor: 24.094

Review 2.  2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Frederick G Kushner; Mary Hand; Sidney C Smith; Spencer B King; Jeffrey L Anderson; Elliott M Antman; Steven R Bailey; Eric R Bates; James C Blankenship; Donald E Casey; Lee A Green; Judith S Hochman; Alice K Jacobs; Harlan M Krumholz; Douglass A Morrison; Joseph P Ornato; David L Pearle; Eric D Peterson; Michael A Sloan; Patrick L Whitlow; David O Williams
Journal:  J Am Coll Cardiol       Date:  2009-12-01       Impact factor: 24.094

3.  Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases.

Authors:  C L Bennett; P D Weinberg; K Rozenberg-Ben-Dror; P R Yarnold; H C Kwaan; D Green
Journal:  Ann Intern Med       Date:  1998-04-01       Impact factor: 25.391

4.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

5.  Management of clopidogrel hypersensitivity without drug interruption.

Authors:  Kimberly L Campbell; John R Cohn; David L Fischman; Paul Walinsky; Raghurum Mallya; Waseem Jaffrani; Michael P Savage
Journal:  Am J Cardiol       Date:  2011-01-19       Impact factor: 2.778

6.  Allergic reactions to clopidogrel and cross-reactivity to other agents.

Authors:  Juzar Lokhandwala; Patricia J M Best; Yvette Henry; Peter B Berger
Journal:  Curr Allergy Asthma Rep       Date:  2011-02       Impact factor: 4.806

7.  Immediate hypersensitivity and delayed hypersensitivity to clopidogrel.

Authors:  D Gutiérrez-Fernández; M S Fuentes-Vallejo; M D Rueda-Ygueravides; A Foncubierta-Fernández; A León-Jiménez
Journal:  Allergol Immunopathol (Madr)       Date:  2007 Sep-Oct       Impact factor: 1.667

Review 8.  Clopidogrel desensitization: case report and review of published protocols.

Authors:  Phillip Owen; John Garner; Lawrence Hergott; Robert Lee Page
Journal:  Pharmacotherapy       Date:  2008-02       Impact factor: 4.705

Review 9.  The evolution of antiplatelet therapy in the treatment of acute coronary syndromes: from aspirin to the present day.

Authors:  Dominick J Angiolillo
Journal:  Drugs       Date:  2012-11-12       Impact factor: 9.546

10.  Frequency of allergic or hematologic adverse reactions to ticlopidine among patients with allergic or hematologic adverse reactions to clopidogrel.

Authors:  Juzar O Lokhandwala; Patricia J M Best; Joseph H Butterfield; Kimberly A Skelding; Thomas Scott; James C Blankenship; Jeremy W Buckley; Peter B Berger
Journal:  Circ Cardiovasc Interv       Date:  2009-07-22       Impact factor: 6.546

View more
  3 in total

Review 1.  Hypersensitivity reactions to modern antiplatelet and anticoagulant drugs.

Authors:  Kathrin Scherer Hofmeier
Journal:  Allergo J Int       Date:  2015-03-14

2.  Work up for the clopidogrel hypersensitivity that led to recognising the undiagnosed myelodysplastic syndrome.

Authors:  Yoo Sang Baek; Jung Woo Lee; Jiehyun Jeon
Journal:  J Geriatr Cardiol       Date:  2016-03       Impact factor: 3.327

3.  Small-Vessel Vasculitis After ST-Segment Elevation Myocardial Infarction: Clopidogrel or Amiodarone?

Authors:  Saskia Lehr; Frank Meiss; Dimitra Kiritsi; Leonidas Tsakiris
Journal:  JACC Case Rep       Date:  2022-08-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.